| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,521 | 15,369 | 16,130 | 16,301 | | Cost of Revenue | 5,039 | 5,030 | 5,764 | 6,145 | | | Gross Profit | 9,482 | 10,339 | 10,366 | 10,156 | | | Operating Expenses | | Research Development | 3,363 | 3,398 | 3,505 | 4,787 | | Selling General and Administrative | 7,437 | 7,969 | 8,498 | 8,437 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 17 | 41 | 41 | 41 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,335) | (1,069) | (1,678) | (3,109) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (920) | 2,393 | (475) | (1,506) | | Earnings Before Interest And Taxes | (545) | 1,324 | (2,153) | (4,615) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (545) | 1,324 | (2,153) | (4,615) | | Income Tax Expense | (231) | (766) | 624 | 29 | | Minority Interest |
-
| (5) | 5 | 99 | | | | Net Income From Continuing Ops | (314) | 2,085 | (2,772) | (4,545) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (314) | 2,085 | (2,772) | (4,545) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($314) | $2,085 | ($2,772) | ($4,545) |
|
0.31% Nasdaq 0.00%
Income Statement
